LDHA and breast cancer: However, the later published evidence that the two breast cancer CSC populations (i.e., ALDH+ and CD24−/CD44+) investigated reside in different areas of primary breast tumors and can transition from one phenotype to the other (19) might affect the reliability of CSC counts in this patient population.